Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

11.47

-0.02 (-0.17%)

At close: Mar 24, 2026, 4:00 PM EDT

11.49

+0.02 (0.17%)

After-hours: Mar 24, 2026, 4:10 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology	25.42M	210.78M	129.01M	-	-
Biotechnology Growth	-87.94%	63.38%	-	-	-
Total	25.42M	210.78M	129.01M	-	-
Total Growth	-87.94%	63.38%	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	25.42M	210.78M	129.01M	-	-
United States Growth	-87.94%	63.38%	-	-	-
Total	25.42M	210.78M	129.01M	-	-
Total Growth	-87.94%	63.38%	-	-	-

Source: S&P Global Market Intelligence.